Patients with stroke who receive intra-arterial thrombolysis after thrombectomy are more likely to achieve superior 90-day ...

Ascension Sacred Heart Bay is busting clots to raise awareness about strokes. Doctors say they are seeing an increase in ...

If approved, the targeted IGF-1 fusion protein would become the only treatment available for late-window stroke patients ...

Against all the odds, Roche's Genentech unit has won FDA approval for its clot-busting drug TNKase as a treatment for acute ischaemic stroke, after all but abandoning the project a couple of years ago ...

The intracoronary fibrinolysis infusion joins a host of other failed treatments to improve microvascular obstruction after ...

An individual patient-level meta-analysis shows that tenecteplase, a next-generation thrombolytic, is at least as effective as alteplase for acute stroke — and may be superior.

LOS ANGELES -- The HOPE trial made another case for extending the therapeutic window for IV thrombolysis in acute ischemic stroke, potentially widening the pool of people eligible for therapy. Among ...

An Advanced Stroke Care Centre is a specialized medical facility designed to deliver comprehensive, time-sensitive, and ...

Objectives To evaluate the long-term efficacy of remote ischaemic postconditioning (RIPC) on functional outcomes in patients ...